Author

Hanna Ławnicka

Observed names: H Lawnicka, H. Lawnicka, H. ŁAWNICKA, H. Ławnicka, Hanna Lawnicka

Observed institutions: Medical University of Lodz, Institute of Endocrinology

ORCID: 0000-0001-7305-2598

Observed ORCID: 0000-0001-7305-2598

OpenAlex ID: A5059366197

Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells

2005 · Jan Komorowski, Hanna Jerczyńska, et al. · Life Sciences · 73

Decreased 1-25 Dihydroxyvitamin D3 Concentration in Peripheral Blood Serum of Patients with Thyroid Cancer

2010 · Tomasz Stepien, Roman Krupinski, et al. · Archives of Medical Research · 55

Effect of Somatostatin and Octreotide on Proliferation and Vascular Endothelial Growth Factor Secretion from Murine Endothelial Cell Line (HECa10) Culture

2000 · H. Ławnicka, H. Stępień, et al. · Biochemical and Biophysical Research Communications · 51

Monoclonal anti-TNFalpha antibody (infliximab) in the treatment of patient with thyroid associated ophthalmopathy.

2007 · Jan Komorowski, Joanna Jankiewicz-Wika, et al. · PubMed · 35

Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer

2017 · Tomasz Stępień, Mateusz Brożyna, et al. · Disease Markers · 32

PDF

Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.

2002 · Katarzyna Winczyk, Marek Pawlikowski, et al. · PubMed · 31

Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer

2018 · Ewelina Motylewska, Tomasz Stępień, et al. · Cytokine · 28

Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.

2009 · Katarzyna Winczyk, Julita Fuss-Chmielewska, et al. · PubMed · 26

Melatonin inhibits growth of diethylstilbestrol‐induced prolactin‐secreting pituitary tumor in vitro: possible involvement of nuclear RZR/ROR receptors

2003 · Michal Karasek, Anna Gruszka, et al. · Journal of Pineal Research · 24

PDF

Modulation of ghrelin axis influences the growth of colonic and prostatic cancer cells in vitro

2012 · Hanna Ławnicka, Gabriela Mełeń-Mucha, et al. · Pharmacological Reports · 23

Elevated Peripheral Blood Plasma Concentrations of Tie-2 and Angiopoietin 2 in Patients with Neuroendocrine Tumors

2012 · Gabriela Melen-Mucha, Agata Niedziela, et al. · International Journal of Molecular Sciences · 20

PDF

Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro

2010 · Hanna Lawnicka, Magdalena Kowalewicz-Kulbat, et al. · Cell and Tissue Research · 20

Angiotensin II and its fragments (angiotensins III and IV) decrease the growth of DU-145 prostate cancer in vitro.

2004 · Hanna Ławnicka, Agnieszka M Potocka, et al. · PubMed · 19

GH–RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells

2003 · A. Siejka, H. Ławnicka, et al. · Life Sciences · 19

The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors

2006 · Gabriela Melen-Mucha, Hanna Lawnicka, et al. · Recent Patents on Anti-Cancer Drug Discovery · 18

Somatostatin Analogs and Tumor Localization Do Not Influence Vitamin D Concentration in Patients with Neuroendocrine Tumors

2016 · Ewelina Motylewska, Joanna Gawronska, et al. · Nutrition and Cancer · 17

Inhibitory effect of prolactin on Toxoplasma proliferation in peripheral blood mononuclear cells from patients with hyperprolactinemia

2012 · K. DZITKO, H. ŁAWNICKA, et al. · Parasite Immunology · 17

Growth hormone-releasing hormone stimulates the secretion of interleukin 17 from human peripheral blood mononuclear cells in vitro.

2010 · Tomasz Stepien, Hanna Lawnicka, et al. · PubMed · 16

Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers

2019 · Hanna Lawnicka, Ewelina Motylewska, et al. · Biomedical Papers · 14

PDF

Growth hormone – releasing hormone in the immune system

2024 · Agnieszka Siejka, Hanna Lawnicka, et al. · Reviews in Endocrine and Metabolic Disorders · 13

PDF

Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro

2013 · Ewelina Motylewska, Hanna Lawnicka, et al. · Endokrynologia Polska · 13

PDF

Antineoplastic Action of Growth Hormone-Releasing Hormone (GHRH) Antagonists

2011 · Agnieszka Siejka, Hanna Lawnicka, et al. · Recent Patents on Anti-Cancer Drug Discovery · 13

Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.

2007 · M Pawlikowski, H Lawnicka, et al. · PubMed · 13

Stimulatory effect of growth hormone–releasing hormone (GHRH(1-29)NH2) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro

2009 · Tomasz Stępień, Małgorzata Sacewicz, et al. · Neuropeptides · 12

Inhibition of proliferation, VEGF secretion of human neuroendocrine tumor cell line NCI-H727 by an antagonist of growth hormone-releasing hormone (GH-RH) in vitro

2008 · Małgorzata Sacewicz, Hanna Ławnicka, et al. · Cancer Letters · 11

Works count: 66

Citation count: 768

H-index: 17

I10-index: 29